Brief: Xvivo Machine Perfusion Reimbursed In Dutch Healthcare System
May 12 (Reuters) - Xvivo Perfusion AB XVIVO.ST :
* REIMBURSEMENT ESTABLISHED FOR LUNG AND LIVER TRANSPLANT IN
THE
NETHERLANDS BASED ON RESULTS FROM CLINICAL TRIALS WITH XVIVO'S
LEADING TECHNOLOGIES
* MACHINE PERFUSION FOR LUNGS AND LIVERS IS NOW BEING
REIMBURSED
IN DUTCH HEALTHCARE SYSTEM
Source text for Eikon: ID:nMFN42WlND
Further company coverage: XVIVO.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Xvivo Perfusion AB
See all newsSweden's XVIVO Q3 revenue beat expectations on thoracic sales
Brief: Xvivo Q3 EBIT SEK 28 Million
Brief: Xvivo Receives CE Certificates For Heart Preservation Technology
Brief: XVIVO Gets FDA Approval For Additional Patient Enrollment
Sweden's XVIVO Q2 sales beat estimates, helped by thoracic segment strength